Sunday, July 22, 2018

Alphabet Inc (GOOG) CEO, Google LLC Sundar Pichai Sold $12 million of Shares

CEO, Google LLC of Alphabet Inc (NASDAQ:GOOG) Sundar Pichai sold 10,000 shares of GOOG on 07/18/2018 at an average price of $1198.47 a share. The total sale was $12 million.

Alphabet Inc is a provider of internet content products and portals. Its suite of brands includes Search, Android, YouTube, Apps, Maps & Ads. Alphabet Inc has a market cap of $830.24 billion; its shares were traded at around $1186.96 with a P/E ratio of 51.16 and P/S ratio of 7.24. Alphabet Inc had annual average EBITDA growth of 16.60% over the past ten years. GuruFocus rated Alphabet Inc the business predictability rank of 3-star.

CEO Recent Trades:

CEO, Google LLC Sundar Pichai sold 10,000 shares of GOOG stock on 07/18/2018 at the average price of $1198.47. The price of the stock has decreased by 0.96% since.CEO, Google LLC Sundar Pichai sold 10,000 shares of GOOG stock on 07/05/2018 at the average price of $1113.42. The price of the stock has increased by 6.6% since.CEO, Google LLC Sundar Pichai sold 10,000 shares of GOOG stock on 06/20/2018 at the average price of $1179.07. The price of the stock has increased by 0.67% since.

Directors and Officers Recent Trades:

SVP, Corporate Development David C Drummond sold 5,690 shares of GOOG stock on 07/12/2018 at the average price of $1167.38. The price of the stock has increased by 1.68% since.VP, Chief Accounting Officer Amie Thuener O'toole sold 73 shares of GOOG stock on 07/03/2018 at the average price of $1135.82. The price of the stock has increased by 4.5% since.Director Ann Mather sold 24 shares of GOOG stock on 07/02/2018 at the average price of $1100. The price of the stock has increased by 7.91% since.

For the complete insider trading history of GOOG, click here

.

Thursday, July 19, 2018

Scotts Miracle Gro: The Best Indirect Marijuana Play

There are many ways to invest in the potential marijuana boom. Many are plays for recreational marijuana which will boom if legalization goes as expected. Many are medical plays which are incredibly likely to be successful but the upside is smaller. The last is companies that happen to have a lot to gain from the marijuana industry but aren��t necessarily reliant upon it for success.

This last type is what we find in Scotts Miracle Gro (SMG). This company is one of the biggest lawn care companies in the world and is consistently profitable. On the side however, it has been acquiring business after business in its Hawthorne segment that is focused on hydroponics. This business is positioned primely to be a huge growth factor if marijuana is legalized recreationally. While the company would not be producing and selling its own plants, it offers the necessary solutions prime to enhance the abilities of a marijuana business to produce.

This is positive for multiple reasons. The first is that the regulations relevant to marijuana even if it does get legalized in the majority of the country will be stringent and expensive. To ship and sell marijuana outside of individual states will likely remain difficult and taxation will be expensive. In addition, international production and exports will still be complicated tasks. However, none of that is true when it comes to gardening solutions that can be used for marijuana. As a company that doesn��t sell actual marijuana, it can take advantage of the growth without having to face all the legislation and scrutiny of the producers.

To see how Hawthorne is growing and is positioned we can look at their finances and some of their recent acquisitions.

Each of these companies either officially or unofficially has a different play in the legal marijuana business: Botanicare is a nutrients company that sells nutrient systems for hydroponics to grow marijuana. The company sells nutrients that range from home growers to commercial applications. Agrolux is a provider or growing lights used for indoor hydroponic growing. This is a similar acquisition to Gavita which is also a large lights player in the hydroponics space. All these acquisitions in the last two plus years have been done with the goal of taking a large portion of the overall hydroponics business. As this is the primary way to grow high quality marijuana, we can see that hydroponics command a higher price as it is the primary indoor growing technique. It is pretty clear why this company should considered a real marijuana play as it has put significant resources towards the future of the marijuana industry.

We can see how committed the company is to this play by the percent of assets devoted to the Hawthorne segment of the business. While the segment last quarter only made up just over 13% of the companies assets, it now comprises nearly 18.6%. This shows that the company sees this segment as a driver of growth and wants to increase its exposure to the business.

The truth is this makes complete sense for the business. Marijuana is one of those industries that has the potential to be absolutely massive if controls are reduced. While the fear of legislation that will slow or stop the spreading of the legalization of marijuana have caused marijuana stocks to command lower valuations as the risks are huge, this is not true for SMG as the company has the majority of its current business stemming from other segments. The company derives more than 90% of its sales from its U.S. consumer gardening business. This means that even if speed of legalization begins to slow, the company is still a legitimate gardening business. This play is not boom or bust or high risk like the rest of the industry, it is a real business with the assets in place to take advantage of a huge growth opportunity.

In addition, as the chart below shows, the marijuana industry is already becoming at least partially legal in a large portion of the country. However, it also shows how much room there is to grow.

One of the largest wins for the marijuana industry could be coming soon as the New York Health Department just suggested that the pros of legalizing marijuana outweigh the cons. This study may be a catalyst not just for legalization in NY but also for other states that are on the fence. Many states have held out due to fear of the health of its citizens but if this report has the sway that it seems, many states may start to consider legalization as a way to increase tax revenues.

This chart below shows how much revenue states get from each tax source. To show how big of an impact excise taxes on substances can have, a look at the amount of taxes from alcohol is pretty indicative. This should help the prospects of marijuana companies such as MJ Holdings (OTCPK:MJNE) and General Cannabis Corp. (OTCQX:CANN)

Alcohol Sales U.S.:

While the marijuana industry is not predicted to be even close to as large as the massive alcohol industry, it has already started to make a positive dent in the taxes of its recreational legal states. As other states want in on the action and it gains support from health professionals, it is likely legalization will continue to sweep across the country. Even the red states are starting to get in the mix.

Disclosure: I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.

I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Editor's Note: This article covers one or more stocks trading at less than $1 per share and/or with less than a $100 million market cap. Please be aware of the risks associated with these stocks.

Friday, July 13, 2018

UniCredit (UCG) PT Set at €21.00 by Royal Bank of Canada

Royal Bank of Canada set a €21.00 ($24.42) target price on UniCredit (BIT:UCG) in a research report released on Monday. The firm currently has a buy rating on the stock.

A number of other research analysts also recently commented on the stock. UBS Group set a €18.70 ($21.74) price objective on shares of UniCredit and gave the company a buy rating in a research note on Monday. Morgan Stanley set a €19.00 ($22.09) price objective on shares of UniCredit and gave the company a buy rating in a research note on Tuesday, July 3rd. JPMorgan Chase & Co. set a €20.00 ($23.26) price objective on shares of UniCredit and gave the company a buy rating in a research note on Thursday, June 28th. Oddo Bhf set a €19.50 ($22.67) price objective on shares of UniCredit and gave the company a buy rating in a research note on Monday, June 18th. Finally, Jefferies Financial Group set a €20.00 ($23.26) price objective on shares of UniCredit and gave the company a buy rating in a research note on Monday, June 11th. Eight research analysts have rated the stock with a buy rating, The company currently has a consensus rating of Buy and an average price target of €20.40 ($23.72).

Get UniCredit alerts:

BIT UCG opened at €17.22 ($20.02) on Monday. UniCredit has a 12 month low of €12.82 ($14.91) and a 12 month high of €18.38 ($21.37).

UniCredit Company Profile

UniCredit S.p.A. operates as a commercial bank. The company operates through Commercial Banking Italy, Commercial Banking Germany, Commercial Banking Austria, Corporate & Investment Banking, Central and Eastern Europe, Fineco, Group Corporate Centre, and Non-Core segments. It offers retail, corporate, and private banking services; credit, trading, and investment services; leasing and factoring services; transactional, investment, and credit products and services; insurance solutions; and structured financing, and hedging and treasury solutions.

Analyst Recommendations for UniCredit (BIT:UCG)

Tuesday, July 10, 2018

Lendingblock (LND) 24 Hour Volume Tops $2,982.00

Lendingblock (CURRENCY:LND) traded down 2.4% against the dollar during the twenty-four hour period ending at 15:00 PM ET on July 7th. In the last week, Lendingblock has traded 10.8% lower against the dollar. Lendingblock has a market capitalization of $3.80 million and $2,982.00 worth of Lendingblock was traded on exchanges in the last day. One Lendingblock token can now be bought for approximately $0.0064 or 0.00000098 BTC on popular cryptocurrency exchanges including DDEX, IDEX and HitBTC.

Here is how similar cryptocurrencies have performed in the last day:

Get Lendingblock alerts: XRP (XRP) traded 0.9% lower against the dollar and now trades at $0.47 or 0.00007187 BTC. Stellar (XLM) traded 1.6% lower against the dollar and now trades at $0.20 or 0.00003104 BTC. IOTA (MIOTA) traded 0.9% lower against the dollar and now trades at $1.05 or 0.00016022 BTC. Tether (USDT) traded down 0.1% against the dollar and now trades at $1.00 or 0.00015329 BTC. NEO (NEO) traded down 0.9% against the dollar and now trades at $37.21 or 0.00567889 BTC. TRON (TRX) traded 1.1% lower against the dollar and now trades at $0.0364 or 0.00000555 BTC. Binance Coin (BNB) traded 4.3% higher against the dollar and now trades at $14.07 or 0.00214833 BTC. VeChain (VET) traded 2.4% lower against the dollar and now trades at $2.45 or 0.00037325 BTC. Ontology (ONT) traded down 4.2% against the dollar and now trades at $4.52 or 0.00069031 BTC. Zilliqa (ZIL) traded down 5.6% against the dollar and now trades at $0.0801 or 0.00001223 BTC.

Lendingblock Profile

Lendingblock’s genesis date was March 5th, 2018. Lendingblock’s total supply is 1,000,000,000 tokens and its circulating supply is 591,472,963 tokens. The official message board for Lendingblock is www.lendingblocklibrary.com. The Reddit community for Lendingblock is /r/Lendingblock and the currency’s Github account can be viewed here. The official website for Lendingblock is lendingblock.com. Lendingblock’s official Twitter account is @lendingblock.

Buying and Selling Lendingblock

Lendingblock can be traded on the following cryptocurrency exchanges: DDEX, IDEX and HitBTC. It is usually not currently possible to purchase alternative cryptocurrencies such as Lendingblock directly using US dollars. Investors seeking to trade Lendingblock should first purchase Ethereum or Bitcoin using an exchange that deals in US dollars such as Coinbase, GDAX or Changelly. Investors can then use their newly-acquired Ethereum or Bitcoin to purchase Lendingblock using one of the aforementioned exchanges.

new TradingView.widget({ “height”: 400, “width”: 650, “symbol”: “LNDUSD”, “interval”: “D”, “timezone”: “Etc/UTC”, “theme”: “White”, “style”: “1”, “locale”: “en”, “toolbar_bg”: “#f1f3f6”, “enable_publishing”: false, “hideideas”: true, “referral_id”: “2588”});

Monday, July 9, 2018

IoT Chain (ITC) Hits Market Cap of $30.80 Million

IoT Chain (CURRENCY:ITC) traded down 5.2% against the dollar during the one day period ending at 17:00 PM E.T. on July 6th. IoT Chain has a market cap of $30.80 million and $4.88 million worth of IoT Chain was traded on exchanges in the last 24 hours. Over the last seven days, IoT Chain has traded up 3.1% against the dollar. One IoT Chain token can currently be bought for $0.51 or 0.00007787 BTC on popular exchanges including Bibox, Huobi, OKEx and Kucoin.

Here’s how related cryptocurrencies have performed over the last 24 hours:

Get IoT Chain alerts: XRP (XRP) traded 0.2% lower against the dollar and now trades at $0.48 or 0.00007239 BTC. Stellar (XLM) traded up 1.6% against the dollar and now trades at $0.20 or 0.00003117 BTC. IOTA (MIOTA) traded down 6.1% against the dollar and now trades at $1.06 or 0.00016160 BTC. Tether (USDT) traded down 0% against the dollar and now trades at $1.00 or 0.00015290 BTC. NEO (NEO) traded 5.5% lower against the dollar and now trades at $37.70 or 0.00573970 BTC. TRON (TRX) traded down 2.3% against the dollar and now trades at $0.0367 or 0.00000559 BTC. Binance Coin (BNB) traded down 2% against the dollar and now trades at $13.46 or 0.00204973 BTC. VeChain (VET) traded up 0.5% against the dollar and now trades at $2.50 or 0.00038098 BTC. Ontology (ONT) traded 3.8% lower against the dollar and now trades at $4.76 or 0.00072537 BTC. Zilliqa (ZIL) traded 2% higher against the dollar and now trades at $0.0852 or 0.00001297 BTC.

About IoT Chain

IoT Chain was first traded on November 24th, 2017. IoT Chain’s total supply is 100,000,000 tokens and its circulating supply is 60,204,425 tokens. The Reddit community for IoT Chain is /r/itcofficial and the currency’s Github account can be viewed here. IoT Chain’s official website is iotchain.io. IoT Chain’s official Twitter account is @IoT_Chain.

Buying and Selling IoT Chain

IoT Chain can be bought or sold on the following cryptocurrency exchanges: OKEx, Bibox, Huobi and Kucoin. It is usually not possible to buy alternative cryptocurrencies such as IoT Chain directly using US dollars. Investors seeking to acquire IoT Chain should first buy Ethereum or Bitcoin using an exchange that deals in US dollars such as Changelly, Coinbase or GDAX. Investors can then use their newly-acquired Ethereum or Bitcoin to buy IoT Chain using one of the aforementioned exchanges.

Saturday, July 7, 2018

Top 10 Small Cap Stocks To Own Right Now

tags:ACHN,PQ,CNR,FCEL,

Small cap health and wellness and Cannabidiol (CBD) stock Gridiron BioNutrients (OTC: GMVP) is getting some extra celebrity attention as the Company is sponsoring a Hole at the annual NFL Alumni Celebrity Gold Classic - a Super Bowl of Golf qualifying tournament as the winning team will represent the NFL Alumni Pro Bowl tournament at the 2018 Super Bowl of Golf at TPC Las Vegas in Las Vegas. The tournament is going on right now until 3 PM with�groups of four paired with a celebrity captain to compete in a team scramble tournament

Gridiron BioNutrients is a�nutraceutical innovator specializing in cannabidiol health health and wellness products that was founded by Darren Long, a former NFL tight-end and 3x All American College Football Player who became an advocate of health and proper nutrition as a result of the symptoms from Chronic Traumatic Encephalopathy (CTE) or brain concussions. Current innovative CBD products include Gridiron MVP�� water, Gridiron MVP�� concentrate, Gridiron CBD H2O Probiotics�� water, Gridiron Premium Hemp Salve, Gridiron Premium Hemp Oil and Gridiron Premium Hemp Oil Capsules plus there are plans to roll-out additional products over the next twelve months.

Top 10 Small Cap Stocks To Own Right Now: Achillion Pharmaceuticals Inc.(ACHN)

Advisors' Opinion:
  • [By Keith Speights]

    Skeptics might deride a comparison of Inovio Pharmaceuticals, Inc. (NASDAQ:INO) and Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) as an exercise in finding the biggest loser. Both companies continue to post huge net losses every quarter, and their stocks are down by at least 30% over the last 12 months.

  • [By Stephan Byrd]

    Achillion Pharmaceuticals (NASDAQ:ACHN) has been given an average recommendation of “Hold” by the nine brokerages that are currently covering the firm, MarketBeat reports. Two analysts have rated the stock with a sell rating, four have issued a hold rating and three have issued a buy rating on the company. The average 12 month price target among analysts that have covered the stock in the last year is $5.20.

  • [By Lisa Levin] Gainers Avenue Therapeutics, Inc. (NASDAQ: ATXI) rose 29.4 percent to $5.50 in pre-market trading after the company disclosed that its first pivotal Phase 3 trial of IV tramadol achieved the primary and key secondary endpoints. MB Financial, Inc. (NASDAQ: MBFI) rose 16.8 percent to $51.00 in pre-market trading. Fifth Third Bancorp (NASDAQ: FITB) agreed to acquire MB Financial for $54.70 per share in cash and stock. LiveXLive Media, Inc. (NASDAQ: LIVX) rose 9.3 percent to $5.40 in pre-market trading after falling 28.92 percent on Friday. Celyad SA (NASDAQ: CYAD) shares rose 9 percent to $29.30 in pre-market trading after climbing 3.26 percent on Friday. Ethan Allen Interiors Inc. (NYSE: ETH) rose 6.7 percent to $26.40 in pre-market trading after gaining 1.64 percent on Friday. Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) rose 5.4 percent to $3.90 in pre-market trading after gaining 3.06 percent on Friday. Acacia Communications, Inc. (NASDAQ: ACIA) rose 5.2 percent to $34.70 in pre-market trading after gaining 1.38 percent on Friday. Westinghouse Air Brake Technologies Corporation (NYSE: WAB) rose 5.1 percent to $100 in pre-market trading. General Electric Company (NYSE: GE) agreed to merge its transportation unit with Wabtec. Sunrun Inc. (NASDAQ: RUN) shares rose 4.7 percent to $11.50 in pre-market trading. Nasdaq, Inc. (NASDAQ: NDAQ) shares rose 4.3 percent to $93.98 in the pre-market trading session. LaSalle Hotel Properties (NYSE: LHO) shares rose 4.2 percent to $33.25 in pre-market trading. Blackstone Group LP (NYSE: BX) will buy LaSalle Hotel Properties in a $4.8 billion deal, Bloomberg reported. Monro, Inc. (NASDAQ: MNRO) shares rose 4 percent to $58.35 in pre-market trading as the company posted upbeat quarterly earnings and disclosed that it has acquired Free Service Tire. HUYA Inc. (NYSE: HUYA) rose 3.7 percent to $19.75 in pre-market trading after falling 4.80 percent on Friday.

    Find out what's going

  • [By Ethan Ryder]

    Achillion Pharmaceuticals (NASDAQ:ACHN) – Research analysts at B. Riley reduced their FY2018 EPS estimates for shares of Achillion Pharmaceuticals in a research note issued to investors on Wednesday, May 2nd. B. Riley analyst M. Kumar now anticipates that the biopharmaceutical company will earn ($0.58) per share for the year, down from their previous estimate of ($0.55). B. Riley has a “Neutral” rating and a $3.50 price objective on the stock. B. Riley also issued estimates for Achillion Pharmaceuticals’ FY2019 earnings at ($0.64) EPS, FY2020 earnings at ($0.71) EPS, FY2021 earnings at ($0.70) EPS and FY2022 earnings at ($0.84) EPS.

  • [By Shane Hupp]

    News articles about Achillion Pharmaceuticals (NASDAQ:ACHN) have trended somewhat positive this week, Accern Sentiment reports. The research firm ranks the sentiment of press coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Achillion Pharmaceuticals earned a media sentiment score of 0.16 on Accern’s scale. Accern also gave news articles about the biopharmaceutical company an impact score of 46.941587509483 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.

Top 10 Small Cap Stocks To Own Right Now: Petroquest Energy Inc(PQ)

Advisors' Opinion:
  • [By Ethan Ryder]

    News headlines about Petroquest Energy (NYSE:PQ) have been trending somewhat positive recently, Accern Sentiment Analysis reports. Accern identifies negative and positive news coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Petroquest Energy earned a coverage optimism score of 0.05 on Accern’s scale. Accern also gave news stories about the energy company an impact score of 47.638327846877 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the near future.

Top 10 Small Cap Stocks To Own Right Now: China Metro-Rural Holdings Limited(CNR)

Advisors' Opinion:
  • [By Joseph Griffin]

    Shares of Canadian National Railway (TSE:CNR) (NYSE:CNI) have been given an average recommendation of “Buy” by the eleven research firms that are covering the firm, MarketBeat reports. One investment analyst has rated the stock with a hold recommendation and six have issued a buy recommendation on the company. The average 12-month price target among brokerages that have updated their coverage on the stock in the last year is C$109.36.

  • [By Max Byerly]

    Canadian National Railway (NYSE:CNI) (TSE:CNR) – Cormark raised their Q3 2018 earnings per share (EPS) estimates for Canadian National Railway in a research report issued to clients and investors on Tuesday, April 10th. Cormark analyst D. Tyerman now expects that the transportation company will post earnings per share of $1.15 for the quarter, up from their previous estimate of $1.14.

  • [By Shane Hupp]

    Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp cut its position in Canadian National Railway (NYSE:CNI) (TSE:CNR) by 21.1% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,956,400 shares of the transportation company’s stock after selling 522,300 shares during the period. Canadian National Railway accounts for about 1.7% of Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp’s investment portfolio, making the stock its 7th biggest position. Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp owned 0.27% of Canadian National Railway worth $184,215,000 at the end of the most recent reporting period.

  • [By Shane Hupp]

    Wall Street analysts expect that Canadian National Railway (NYSE:CNI) (TSE:CNR) will announce $1.02 earnings per share (EPS) for the current quarter, according to Zacks Investment Research. Seven analysts have provided estimates for Canadian National Railway’s earnings, with the highest EPS estimate coming in at $1.06 and the lowest estimate coming in at $0.97. Canadian National Railway reported earnings per share of $1.00 in the same quarter last year, which would suggest a positive year over year growth rate of 2%. The company is expected to announce its next quarterly earnings results on Tuesday, July 24th.

  • [By Ethan Ryder]

    State of Tennessee Treasury Department lessened its stake in shares of Canadian National Railway (NYSE:CNI) (TSE:CNR) by 1.6% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 842,775 shares of the transportation company’s stock after selling 13,507 shares during the quarter. State of Tennessee Treasury Department owned about 0.11% of Canadian National Railway worth $61,565,000 as of its most recent filing with the SEC.

Top 10 Small Cap Stocks To Own Right Now: FuelCell Energy Inc.(FCEL)

Advisors' Opinion:
  • [By Paul Ausick]

    FuelCell Energy Inc. (NASDAQ: FCEL) posted an increase of 17.8% in short interest during the period. Some 6.9 million shares were short as of May 15. The stock closed at $1.88 on Thursday, down about 1.1% for the day, in a 52-week range of $0.93 to $2.49. Shares traded up about 1.4% in the short interest period, and days to cover rose from eight to 14.

  • [By Paul Ausick]

    FuelCell Energy Inc. (NASDAQ: FCEL) posted a decrease of 4% in short interest during the period. Some 7.42 million shares were short as of June 15. The stock closed at $1.37 on Tuesday, down about 1.4% for the day, in a 52-week range of $1.18 to $2.49. Shares traded down more than 10% in the short interest period, and days to cover dropped from 17 to six.

  • [By Ethan Ryder]

    FuelCell Energy (NASDAQ: FCEL) and Integer (NYSE:ITGR) are both oils/energy companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, dividends, earnings, profitability, valuation, institutional ownership and risk.

Friday, July 6, 2018

Microsoft: Low Downside Risk, But Potential For Innovation-Driven Upside With Cloud And GitHub

Even as Microsoft's (MSFT) stock has been flat or down this month since the GitHub acquisition, I believe in the long-term GitHub has significant chances in boosting a variety of Microsoft software and Internet services segments, even outside of cloud computing, to help it successfully compete and still grow.

Furthermore, Microsoft's valuation metrics, stock characteristics, and largely steady business outside of cloud all makes its downside risk low in my opinion aside from a market-wide downturn.

With Microsoft Azure and its cloud segment as a whole continuing to show strong expansion in a still-rapidly growing sector, with the low potential drop-risk, make it have an exciting upside that could manifest itself in significant gains.

(Source: The Verge)

GitHub, Cloud Computing, And Staying Competitive In A Constantly Rapidly Innovative Sector

Last month I discussed with members of Tech Investment Insights why I believe Microsoft's acquisition of GitHub could be disruptive to not only its cloud segment but all its software business lines. While Microsoft stock since then has been relatively stagnant, even declining slightly beyond the broader market indexes' declines.

Chart MSFT data by YCharts

I think however GitHub will begin to contribute slightly to Microsoft's bottom line itself as a segment in upcoming earnings quarters, but more particularly its innovative potential augmentation of the development of Microsoft's other software segments.

GitHub, as a hosting, development, and collaboration platform for code, is immensely valuable to Microsoft in its potential to push efficiencies and innovation. While the $7.5 billion acquisition cost seems high, that it will be in stock both lessens the otherwise potential debt burden on Microsoft and explains partially why the stock has been slightly depressed the past month.

Nonetheless, at a current market cap of over $766 billion the $7.5 billion in stock acquisition cost won't be much of a long-term transformation of shareholder equity.

Given that apparently the GitHub deal had already mostly closed by its leak in early June, with the final terms expected to fully close by the end of the year, we could see it begin to make an impact even sooner than expected.

Yet the primary benefit for GitHub remains in the long-run as a way to keep Microsoft's software capabilities competitive, particularly against its innovative challengers Amazon (AMZN) and Google (GOOGL) in cloud.

(Source: CNBC)

As I've previously discussed, cloud computing has been immensely profitable for Microsoft as a high-margin product despite its current size. Just like with Amazon, cloud has helped even these massive companies see significant earnings growth even at their current enormous market caps.

The cloud computing sector is expected to continue to expand at rapid levels and Microsoft has been slowly gaining market share in it, even though with the vast amounts of sector growth happening market share is not as essential as for a mature industry.

GitHub's boost will slowly manifest itself over time in unpredictable ways, as innovation and research development often is a constant hit-or-miss chance cube. It likely still will have enough brain trust power to create major benefits to Microsoft's cloud computing competitiveness and even potentially its other various Internet services and software products, possibly including its unclear but determined forays into the cryptocurrency and Blockchain sector.

Chart MSFT data by YCharts

Valuation-wise, Microsoft currently stands at a TTM price-to-earnings ratio of 27.50 based on GAAP EPS of $3.60. There is only 0.73% in short interest and over 72.19% of the stock is held by institutions, which in my opinion demonstrates a firm and steady floor for the company's stock as well.

Even if significant accelerated growth does not materialize, the P/E ratio is only very slightly a growth-ratio and the stocks other characteristics do not give the appearance of major downside risk, barring market-wide downturns.

One market-wide factor that is currently creating wider turbulence and particularly among tech companies are tariffs. Though the global tariffs conflict could be disruptive to Microsoft activities in building its data-centers and the few hardware products it does shift, it seems at the moment many of its cloud computing, software, LinkedIn, and other product lines may not be affected significantly.

Conclusion

Overall, I believe Microsoft was already on a slight growth trajectory before GitHub's acquisition, due to the effect of its cloud computing segment and stability of its other business lines.

GitHub's acquisition upgrades that to a more moderate growth expectation, as GitHub could potentially create widespread and long-lasting innovative advancements that helps Microsoft compete in cloud and other software and Internet services business lines.

Furthermore, I see little downside risk in the company unless there is a wider market downturn in which case the company can only resist the tide so much. In the meantime it appears the company has strong ins

Thursday, July 5, 2018

What's the Best Way Out of This Fund's Exorbitant Transaction Fees?

It would be hard to find a podcast-hosting duo more totally invested in answering your financial questions than Alison Southwick and Robert Brokamp -- they put "Answers" in the show's name, for goodness' sake! And this week, they're at it again, combing through the Motley Fool Answers mailbag in search of conundrums to address for their listeners. But because three heads are better than two, for this episode, they've enlisted the help of Sean Gates, a financial planner with Motley Fool Wealth Management.

In this segment, they consider the case of Jeff, whose wife has a Roth IRA with Fidelity that contains a Vanguard�target date fund. Every time they add any money to the fund, they have to pay a $75 fee. That's both too much, and depressingly normal. But yes, there are maneuvers to get away from those fees.

Sean Gates is an employee of Motley Fool Wealth Management, a separate, sister company of The Motley Fool, LLC. The views of Sean Gates and Motley Fool Wealth Management are not the views of The Motley Fool, LLC and should not be taken as such.

A full transcript follows the video.

This video was recorded on June 26, 2018.

Alison Southwick: Next question comes from Jeff. "My wife has a Roth IRA with Fidelity in which we bought a Vanguard target-date fund. I recently realized that every time we add money to the fund, they charge us a $75 fee!" Woof! "Would you recommend waiting until we have a large enough sum of money to add to the fund to make the fee 1-2% of the investment, or perhaps open an account with Vanguard and transfer the fund? Or maybe there's a better option than those two. My wife and I each already have a Roth IRA and 401(k), so if I transferred the fund to a normal account, wouldn't I get taxed on the dividends?"

Robert Brokamp: What he has encountered is what's called a transaction fee. When you open up a regular old brokerage account and you buy a stock, you pay a commission. It's usually $7-10. But when you buy a mutual fund, it can cost you -- as we're seeing here -- $75, unless it's a non-transaction fee fund -- you'll see a little NTF on the broker's website. One thing he might consider doing is selling that fund and buying a fund that is an NTF fund.

I will point out, though, there's a reason why Vanguard's fund in this situation is charging that. To be in these big brokerages, a mutual fund company has to pay Fidelity a fee to be on their fund marketplace. And in the end, the person who owns that fund is going to pay that. I've read an article that says the average is they're paying the broker 0.4% just to be on their platform.

So, to a certain degree, you're going to pay for it either way. If you love Vanguard's Target retirement fund, my recommendation would be then to transfer the money to Vanguard.

The second part of your question, about how you've said that you and your wife both have a Roth IRA and 401(k), it sounds like you're not aware of the fact that you can transfer this money to those accounts. You don't have to transfer the money to a taxable account. If you did do that, that would be considered distribution and it would be taxable, you'd pay penalties. You can just transfer it to your existing accounts. It might be that you're aware of the annual contribution limits to those accounts, and you might be confusing those contribution limits with what you can transfer. There's no limit on how much money you can transfer from one account to another. If you transferred this Roth IRA with Fidelity to another Roth IRA, that wouldn't affect how much money you could then contribute as a regular contribution. I'm just assuming, reading between the lines there, what the confusion is there.

Sean Gates: The only other thing I would add is, I don't think I would recommend waiting to collect a large sum of money before purchasing a mutual fund. I think that waiting has an opportunity cost associated with it that you might be discounting. Looking for alternate funds to invest in that don't have that commission would be a better option than just waiting until you have some sum of money to cover the cost of the $75 transaction fee.

Brokamp: We've talked about studies before that have looked at dollar-cost averaging vs. lump sum investing. You're better off just getting the money in as soon as you can -- just to back up what you said there. Having your money just sit around in a cash account until you've accumulated enough, there's a cost to that.